🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this trial is to investigate the effect of BI 730357 ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2020-10-20
Trial ID
NCT04590937
Treatments Being Tested
The objective of the present study is to contribute to establishing in vivo...
Status
Completed
Location
Department of Pharmacology I, University Hospital Cologne
Start Date
2016-04
Trial ID
NCT02743260
Treatments Being Tested
To study the Pharmacokinetics (PK) parameters of montelukast, flurbiprofen,...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02456844
An open label, balanced, randomized, single-dose, two-treatment, two-sequen...
Status
Completed
Location
ClinSync Clinical Research Pvt. Ltd.
Start Date
2019-03-10
Trial ID
NCT03909529
Treatments Being Tested
This study will be conducted as a single-center, open-label, 2-period, sing...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2014-10
Trial ID
NCT02300350
The primary objectives of this study are the following: * To evaluate the ...
Status
Completed
Location
PPD
Start Date
2019-03-11
Trial ID
NCT03856970
Treatments Being Tested
The purpose of this study is to assess the effect of multiple doses of isav...
Status
Completed
Location
Parexel International
Start Date
2012-03
Trial ID
NCT01582412
Treatments Being Tested
To evaluate the Growth Modulation Index (GMI) of the combination of metrono...
Status
Terminated
Location
Western Regional Medical Center
Start Date
2013-04
Trial ID
NCT01887288
Treatments Being Tested
The purpose of this study is to assess pharmacokinetic concentrations of mu...
Status
Completed
Location
BioVirtus Research Site
Start Date
2016-04
Trial ID
NCT02740712
The objective of this trial is to assess the effect of BI 3000202 on the ph...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2025-11-05
Trial ID
NCT07215260
Treatments Being Tested